Baker McKenzie has advised KeBeK Private Equity in the sale of all shares of Belgian specialty chemicals distributor Alphamin SA and its US subsidiary based in New Jersey to the German global market leader in chemical distribution Brenntag. With this transaction, KeBeK Private Equity closes its fourth deal of the past few months.
 
KeBeK Private Equity acquired Alphamin SA in 2014, having successfully implemented the optimization of its product portfolio since then. Alphamin's speciality polymer and waxes serves a wide range of industries worldwide. For the financial year ended 30 June 2018, the business generated a turnover of approximately EUR 45 million.
 
Brentagg Group indicated that Alphamin's global reach, its product portfolio and expertise represented the perfect opportunity to improve Brenntag’s technical resources, to expand its presence in attractive niche markets and to support its global or pan-regional strategy for certain product groups such as waxes.
 
The Baker McKenzie Brussels team advising KeBeK Private Equity on the sale of Alphamin SA included M&A lawyers led by Koen Vanhaerents and supported by Arne Naert. KeBeK Private Equity was further assisted by BNP Paribas Fortis.